Enhance your practice with CMEand tools that focus on the managementand treatment of patients with cancer.
6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
Steve Jackson, PharmD
Lyudmila A. Bazhenova, MD
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Assessing and Interpreting pCR in Perioperative NSCLC
Alexander Spira, MD, PhD, FACP
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Erica L. Mayer, MD, MPH
Decoding epNECs: Diagnostic Challenges and Emerging Strategies
Brian P. McDonough, MD, FAAFP
Andrew E. Hendifar, MD
Key Differences in Pulmonary and Extrapulmonary NEC Management
Alexandria May, PharmD, BCPS
Lowell B. Anthony, MD, FACP
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD
Optimizing Treatment Intensity in Early-Stage TNBC
Roberto Leon-Ferre, MD
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Jennifer Johnson, MD, PhD
Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
Adam J. Luginbuhl, MD
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
Navigating Classification of High-Grade Neuroendocrine Neoplasms
Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Chandrikha Chandrasekharan, MBBS
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Amy Comander, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.